Navigating Pharma Supply with Regional Resilience at CPHI Americas

The global pharmaceutical supply chain is going through a structural transformation. The blueprint for pharmaceutical development and manufacturing, built around global optimization, is being systematically dismantled. Facing global disruptions and trade friction, the industry is shifting toward regionalized, resilience-focused networks.

This reflects the shifting geopolitical landscape, where the historical ease of cross-border trade now faces tariff uncertainty and strategic competition. Recent supply chain events have shown that concentrated production can be easily disrupted by localized crises, regulatory bottlenecks or political instability, leaving downstream markets vulnerable to drug shortages. The physical geography of drug production is now central to national security debates, accelerating the push toward domestic self-sufficiency and trusted regional corridors. Bridging the gap between high-level policy and practical manufacturing reality requires robust cross-sector alignment.

Industry forums like CPHI Americas are more relevant than ever. This year’s event, taking place on 2—4 June at the Pennsylvania Convention Center in Philadelphia, USA, aims to create a space where manufacturers, innovators and key decision-makers can explore commercial strategy, technical capability and supply chain security.

The strategic shift to domestic capacity in contract manufacturing

The pivot toward regionalized supply networks is redefining the geography of manufacturing in the Americas. Even prior to this year’s geopolitical disruption, a 2024 survey, 92% of pharma, biologics and medical device experts agreed that the level of risk in pharma and life sciences supply chains increased over the previous two years.¹

Few companies are wholly abandoning global footprints. Instead, a hybrid model has emerged that balances domestic core capacity with highly integrated regional contract manufacturing partnerships. In the United States, this movement has been catalyzed by legislation encouraging local drug and active pharmaceutical ingredient (API) production to insulate the market against global supply lines.

As pharmaceutical developers seek to protect their production networks without incurring the massive capital expenditures or lengthy timelines associated with site construction, they are increasingly leveraging the established infrastructure of contract partners. These organizations have moved from tactical service vendors to central strategic partners. Reflecting this industry shift, CPHI Americas has transitioned its core focus heavily toward contract development and manufacturing organizations (CDMOs). 

This contract manufacturing focus is mirrored across the CPHI exhibition floor, which will host roughly 250 specialized exhibitors. To reflect the diversifying needs of modern outsourcing, the event has expanded its footprint beyond traditional small-molecule CDMOs to feature a robust biopharma cohort, alongside a newly introduced specialized packaging zone and a contract research organization (CRO) zone. This design encapsulates all the interconnected pieces of contemporary contract manufacturing under a single roof.

Securing the pipeline: Bridging technical innovation and manufacturing quality

Building a resilient regional network requires a high standard of commercial qualification. Recognizing that technology transfer, regulatory compliance and analytical validation represent the primary operational bottlenecks in shifting manufacturing footprints, CPHI Americas has instituted an in-depth qualification process for its attendees this year.

The event is shifting away from generic volume attendance to intentionally curating a high-value buyer demographic. The primary target profiles for the event are specialized decision-makers rooted in research and development (R&D) and quality control (QC). These are the professionals holding proprietary drug pipelines and actively seeking long-term manufacturing partnerships.

By bringing together asset owners with technically proficient CDMOs, the event addresses the critical friction points of modern outsourcing, including:

• Data integrity

• Process scale-up

• Localized regulatory alignment

To support high-value interactions, the CPHI Americas organizing team has altered the registration process, dividing access into trade show-only badges optimized for verified high-value buyers and premium trade show-and-conference badges designed to draw senior executives managing corporate portfolios.

The strategic agenda: Five core content tracks

Translating high-level supply chain strategies into reliable, large-scale production realities involves navigating a complex landscape of operational and regulatory constraints. To address these changing dynamics, CPHI Americas has expanded its agenda into five forward-looking content tracks designed to provide comprehensive insights:

1. U.S. insights: Assessing the evolving localized economic priorities, regulatory changes and the broader financial environment dictating domestic capital allocation.

2. U.S. manufacturing supply chain: Analyzing methods to protect regional sourcing, balancing cost pressures against supply continuity.

3. R&D excellence in biologics: Exploring the complex scale-up, technology transfer and analytical challenges associated with biologics development and advanced therapies.

4. AI and emerging technology: Highlighting advances in predictive algorithms, digital twins and automation designed to optimize production in manufacturing.

5. Market strategy: Evaluating cross-border joint ventures, asset divestments and the shifting competitive landscape governing the broader Americas ecosystem.

Explore the full agenda.

The speaker roster underscores the calibre of insight driving this year’s agenda, with featured names including Richard Pazdur, former director of the FDA Oncology Center of Excellence, Murray Aitken, senior vice president at IQVIA and Sirsij Peshin, chief procurement officer and global lead, source to pay at Pfizer Inc. These voices bring regulatory, market intelligence and procurement perspectives to the programme, connecting high-level industry strategy with the operational decisions now shaping pharmaceutical supply networks.

Discover the full speaker line-up.

Crucially, the agenda bridges the gap between regional industrial policy and hands-on manufacturing execution. By bringing together public sector leaders, policy experts and technical engineering authorities, the event grounds high-level corporate strategy in practical, plant-floor realities.

Fostering long-term partnerships through shared experiences on the exhibition floor

In business-to-business pharmaceutical outsourcing, trust and alignment can help build highly technical, long-term CDMO partnerships. Process validation and technology transfer can take years to execute, requiring deeply collaborative relationships across developers and outsourcing partners.

To move past the often stiff, transactional nature of traditional trade show floors, CPHI Americas has introduced several targeted space concepts engineered to foster organic business relationships, including:

• Match and meet area: A dedicated space for pre-qualified buyers and exhibitors to conduct highly focused, confidential commercial negotiations away from booth traffic.

• Community and networking hub: A less formal environment featuring peer-to-peer roundtables and interactive panels exploring shared operational bottlenecks.

• Growth and development zone: An incubation and meetup space designed specifically to integrate and advance emerging life science professionals into the broader ecosystem.

• Play and connect hub: An activity-driven networking environment featuring a golf simulator and mini-golf course designed to facilitate natural, relationship-driven dialogue.

The play and connect hub, in particular, aims to address a clear corporate hurdle: shared experiences vastly improve the depth and longevity of professional relationship building. By allowing executives to step away from formal pitch decks and connect over casual, shared experiences like golf, the show floor functions as a modern collaborative space.

This ethos of relationship-driven networking extends beyond standard exhibition hours. The event features an evening welcome reception designed to transition daytime business into a more relaxed setting. By moving away from formal structures, the reception encourages attendees to break down corporate hierarchies in favor of candid, peer-to-peer dialogue, further cementing the alliances necessary to navigate today’s complex manufacturing environment.

Coordinating the next phase of the pharmaceutical supply chain

The transition of pharmaceutical manufacturing from globally optimized, low-cost structures to politically resilient, regionalized networks is a significant structural shift. As the industry navigates the complexities of this transition, the need for centralized forums where policy, science and manufacturing capacity can meet has never been more pronounced.

CPHI Americas provides that vital ecosystem. By tightly focusing on contract development and manufacturing, curating a highly qualified R&D and quality audience, and delivering high-quality content, the event moves the industry beyond high-level resilience rhetoric. For pharmaceutical executives looking to fortify their supply chains against future shocks while maintaining commercial viability, CPHI Americas is where strategic intent transforms into practical operational progress.

For pharmaceutical executives looking to fortify their supply chains against future shocks while maintaining commercial viability, CPHI Americas is where strategic intent transforms into practical operational progress.

Register now to join the discussion.

References

1. https://www.tive.com/ed-research-papers/read-how-pharma-supply-chain-leaders-are-mitigating-rising-security-risks-with-visibility-technology

With nearly two decades in exhibitions and events, Sarah Griffin, CEM, brings a strategic, experience-driven approach to connecting the pharmaceutical community. As Event Manager for CPHI Americas at Informa Markets, she is helping shape the event into a high-impact platform for the contract manufacturing ecosystem.